BR112014013541A2 - processo para a recuperação de cloridrato de nalmefeno - Google Patents

processo para a recuperação de cloridrato de nalmefeno

Info

Publication number
BR112014013541A2
BR112014013541A2 BR112014013541A BR112014013541A BR112014013541A2 BR 112014013541 A2 BR112014013541 A2 BR 112014013541A2 BR 112014013541 A BR112014013541 A BR 112014013541A BR 112014013541 A BR112014013541 A BR 112014013541A BR 112014013541 A2 BR112014013541 A2 BR 112014013541A2
Authority
BR
Brazil
Prior art keywords
recovery
nalmefene hydrochloride
nalmefene
hydrochloride
Prior art date
Application number
BR112014013541A
Other languages
English (en)
Other versions
BR112014013541B1 (pt
Inventor
De Faveri Carla
Stivanello Mariano
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48573602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014013541(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of BR112014013541A2 publication Critical patent/BR112014013541A2/pt
Publication of BR112014013541B1 publication Critical patent/BR112014013541B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112014013541-0A 2011-12-06 2012-12-06 Processos para a recuperação e preparação de cloridrato de nalmefeno e composto BR112014013541B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201100948 2011-12-06
DKPA201100948 2011-12-06
PCT/EP2012/074623 WO2013083685A1 (en) 2011-12-06 2012-12-06 Process for recovery of nalmefene hydrochloride

Publications (2)

Publication Number Publication Date
BR112014013541A2 true BR112014013541A2 (pt) 2017-06-13
BR112014013541B1 BR112014013541B1 (pt) 2022-02-15

Family

ID=48573602

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014013541-0A BR112014013541B1 (pt) 2011-12-06 2012-12-06 Processos para a recuperação e preparação de cloridrato de nalmefeno e composto

Country Status (32)

Country Link
US (1) US8841452B1 (pt)
EP (1) EP2788357B1 (pt)
JP (1) JP6086925B2 (pt)
KR (1) KR20140103288A (pt)
CN (1) CN104093721B (pt)
AR (1) AR089080A1 (pt)
AU (1) AU2012347261B2 (pt)
BR (1) BR112014013541B1 (pt)
CA (1) CA2857096C (pt)
CL (1) CL2014001454A1 (pt)
CO (1) CO6970605A2 (pt)
CY (1) CY1118785T1 (pt)
DK (1) DK2788357T3 (pt)
ES (1) ES2622156T3 (pt)
HK (1) HK1202874A1 (pt)
HR (1) HRP20170497T1 (pt)
HU (1) HUE033717T2 (pt)
IL (1) IL232826A (pt)
IN (1) IN2014KN01211A (pt)
JO (1) JO3251B1 (pt)
LT (1) LT2788357T (pt)
ME (1) ME02668B (pt)
MX (1) MX354331B (pt)
PL (1) PL2788357T3 (pt)
PT (1) PT2788357T (pt)
RS (1) RS55817B1 (pt)
RU (1) RU2631652C2 (pt)
SG (1) SG11201402956UA (pt)
SI (1) SI2788357T1 (pt)
TW (1) TWI560170B (pt)
WO (1) WO2013083685A1 (pt)
ZA (1) ZA201404100B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105646508B (zh) * 2016-02-17 2018-02-27 南京卓康医药科技有限公司 一种盐酸纳美芬一水合物的制备方法
US10927121B1 (en) 2019-12-20 2021-02-23 Southwest Research Institute Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate
US20240109907A1 (en) 2021-01-28 2024-04-04 Rhodes Technologies Process for crystallizing nalmefene hydrochloride

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2577947A (en) * 1951-12-11 Manufacture of dihydrocodeinone
US3896226A (en) * 1971-11-26 1975-07-22 Lewinstein Evalina 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts thereof, and use of the same as a narcotic antagonist
US3814768A (en) * 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
ATE402937T1 (de) * 1999-11-09 2008-08-15 Abbott Lab Hydromorphinone and hydrocodeinone compositions and methods for their synthesis
CA2478558C (en) * 2002-03-14 2012-09-11 Euro-Celtique, S.A. Naltrexone hydrochloride compositions
DE602007003197D1 (de) * 2006-03-02 2009-12-24 Mallinckrodt Inc Verfahren zur herstellung von morphinan-6-on-produkten mit geringen konzentrationen von alpha-, beta-ungesättigten ketonverbindungen
CN101652370A (zh) * 2006-12-04 2010-02-17 诺拉姆科有限公司 制备14-羟基可待因酮水平减少的羟考酮的方法
EP2121669A2 (en) 2007-01-30 2009-11-25 Biogen Idec MA, Inc. Furanone compounds and methods of making and using the same
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
SI2435439T1 (sl) 2009-05-25 2016-06-30 H. Lundbeck A/S Priprava nalmefen hidroklorida iz naltreksona
CN101768164B (zh) * 2010-01-25 2011-09-14 海南数尔药物研究有限公司 一种高纯度的盐酸纳洛酮化合物

Also Published As

Publication number Publication date
IL232826A0 (en) 2014-08-03
KR20140103288A (ko) 2014-08-26
JO3251B1 (ar) 2018-09-16
ME02668B (me) 2017-06-20
BR112014013541B1 (pt) 2022-02-15
HRP20170497T1 (hr) 2017-06-02
RU2631652C2 (ru) 2017-09-26
CN104093721B (zh) 2016-05-18
SG11201402956UA (en) 2014-07-30
JP2015504856A (ja) 2015-02-16
MX354331B (es) 2018-02-27
LT2788357T (lt) 2017-04-25
DK2788357T3 (en) 2017-04-24
PT2788357T (pt) 2017-04-24
RS55817B1 (sr) 2017-08-31
AU2012347261B2 (en) 2016-12-01
PL2788357T3 (pl) 2017-07-31
AU2012347261A1 (en) 2014-06-19
CY1118785T1 (el) 2017-07-12
IL232826A (en) 2016-10-31
CL2014001454A1 (es) 2014-10-03
SI2788357T1 (sl) 2017-06-30
CN104093721A (zh) 2014-10-08
IN2014KN01211A (pt) 2015-10-16
HK1202874A1 (en) 2015-10-09
RU2014126489A (ru) 2016-01-27
ZA201404100B (en) 2015-11-25
CA2857096A1 (en) 2013-06-13
CA2857096C (en) 2021-01-19
TWI560170B (en) 2016-12-01
US8841452B1 (en) 2014-09-23
MX2014006705A (es) 2014-07-09
EP2788357B1 (en) 2017-03-01
ES2622156T3 (es) 2017-07-05
WO2013083685A1 (en) 2013-06-13
CO6970605A2 (es) 2014-06-13
JP6086925B2 (ja) 2017-03-01
TW201335110A (zh) 2013-09-01
HUE033717T2 (en) 2017-12-28
EP2788357A1 (en) 2014-10-15
US20140296525A1 (en) 2014-10-02
AR089080A1 (es) 2014-07-30

Similar Documents

Publication Publication Date Title
BR112014005322A2 (pt) processo
BR112014015118A2 (pt) processo para a recuperação intensificada de petróleo
BR112014012414A2 (pt) processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas
BR112014015996A2 (pt) processo
BR112014009302A2 (pt) processo para preparar derivativos de quinolina
BR112014004622A2 (pt) processo para a preparação de isocianatos
BR112012030921A2 (pt) processo para recuperação de petróleo
BR112014008911A2 (pt) processo para a produção de 5-hidroximetilfurfural
BR112014003111A2 (pt) “processo para preparar um composto de 1h-pirazol-5- carbonilcloreto n-substituído e processo para preparar um composto de sulfimina”
BR112014016001A2 (pt) processo
BRPI1014267A2 (pt) processo para a carbonitrificação
BR112013008883A2 (pt) processo para a fabricação de di-hidropteridinonas
BR112015002912A2 (pt) processo para a produção de benzoxazinonas
BR112014015988A2 (pt) processo
BR112013033184A2 (pt) processo
BR112014015999A8 (pt) processo
BR112013022548A2 (pt) processo para a preparação de aminas primárias
BR112015000987A2 (pt) processo para a preparação de 5-fluoro-1h-pirazóis
BR112014014052A2 (pt) processo para a preparação de 5-hidroximetilfurfural
BR112014010327A2 (pt) processo para a preparação de compostos
BR112014013541A2 (pt) processo para a recuperação de cloridrato de nalmefeno
BR112013027652A2 (pt) processo para preparar um composto
BR112014008575A2 (pt) processo para a preparação de ditina-tetracarboximidas
BR112014002093A2 (pt) processo para a formação de um polímero
BR112014004595A2 (pt) processo para a carbonilação de alquenos opcionalmente funcionalizados

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/12/2012, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2752 DE 03-10-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.